Belluscura PLC (GB:BELL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Belluscura PLC, a medical device developer, has reported a doubling in monthly sales of its X-PLOR portable oxygen concentrator in the US, reaching a high of $450,000 in May 2024, and strong sales in China. Concurrently, the company is preparing to release its DISCOV-R portable oxygen concentrator and is proposing to raise £2.4 million through a conditional placing of convertible loan notes. This fundraising is anticipated to support Belluscura’s growth and meet the robust demand for its innovative oxygen concentrators.
For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.